Active Ingredient: SUFENTANIL CITRATE
Proprietary Name: SUFENTANIL CITRATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.05MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A074413
Product Number: 001
Approval Date: Dec 15, 1995
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information